Science Brief · Nutrition
Vitamin D benefits for skin, hair, and mood: what the research actually shows
Vitamin D supports skin barrier defense, is linked in trials to fewer inflammatory acne lesions in deficient people, and is associated with lower rates of multiple hair-loss types. A 2023 meta-analysis of 41 RCTs found it modestly supports mood at doses of 2,000 IU or above.28 The evidence is strongest when correcting a documented deficiency. Test first, then decide.
Vitamin D is one of the most-researched nutrients in modern medicine, and also one of the most misunderstood. It is not quite a vitamin (your body synthesizes it like a hormone), deficiency is genuinely common across all demographics, and its skin, hair, and mood effects are real in the research, but conditional on your starting level. This guide covers what the clinical data actually says, who is most at risk of deficiency, how to get enough, and what you should do before picking a dose.
// What's in this guide
01What vitamin D actually is
Despite the name, vitamin D is not technically a vitamin. Vitamins are nutrients the body cannot produce and must obtain from diet. Vitamin D, on the other hand, is synthesized in your skin when UVB radiation from sunlight converts 7-dehydrocholesterol into pre-vitamin D3, which the liver then hydroxylates into calcidiol (25-hydroxyvitamin D, the measured storage form), and the kidneys convert into calcitriol (1,25-dihydroxyvitamin D), the biologically active hormone.21
Calcitriol binds to the vitamin D receptor (VDR), a nuclear receptor present in virtually every tissue in the body: bone, gut, immune cells, skin, hair follicles, brain, and more. This systemic presence explains why deficiency creates effects across so many different systems at once, and why the molecule's job is broader than just calcium regulation, the role most people associate it with.
The form measured in blood tests is 25-hydroxyvitamin D (written as 25(OH)D). Most labs express this in nanograms per milliliter (ng/mL) or nanomoles per liter (nmol/L). To convert: 1 ng/mL equals approximately 2.5 nmol/L. Deficiency is generally defined as below 20 ng/mL (50 nmol/L), insufficiency as 20 to 29 ng/mL, and adequacy at 30 ng/mL (75 nmol/L) or above. Some research suggests optimal thresholds for specific health outcomes may sit closer to 40 to 50 ng/mL.22
Vitamin D is a hormone precursor produced from sunlight, not a classic dietary vitamin. It regulates hundreds of processes via the VDR receptor found in almost every tissue. The form your doctor tests is 25(OH)D; adequacy starts around 30 ng/mL for most people.
02Who is deficient, and why it is more common than most people think
Vitamin D deficiency is not a niche problem. A 2017 systematic review of 71 studies found that 78% of indoor workers and 80% of shift workers were deficient, compared to significantly lower rates among people with consistent outdoor exposure (mean 25(OH)D of 40.6 nmol/L versus 66.7 nmol/L for outdoor workers).1 A 2024 cross-sectional study of office workers found a mean serum level of just 13.2 ng/mL, with 68% showing bone-density implications from sustained deficiency.2
Several factors compound the risk:
- Latitude and season. UVB intensity is insufficient for vitamin D synthesis at latitudes above roughly 37 degrees North or South during winter months, which covers most of Canada, northern Europe, and much of the United States.
- Melanin concentration. Darker skin requires significantly more UVB exposure to produce the same amount of vitamin D. A meta-analysis of 36 studies found a 77% pooled prevalence of deficiency in dark-skinned migrant populations living at higher latitudes.3 A separate review found African Americans have a 15 to 20-fold higher prevalence of severe deficiency compared to European Americans.4
- Indoor lifestyle. Standard window glass blocks UVB almost entirely. Working indoors all day, even in a sunny climate, contributes almost nothing to vitamin D synthesis.
- Age. Skin's capacity to synthesize vitamin D from UVB exposure declines with age, and older kidneys are less efficient at converting it to the active form.
- Higher body fat. Vitamin D is fat-soluble and sequesters in adipose tissue, making it less bioavailable in the bloodstream at higher body weights.
Most people who work indoors, live at northern or southern latitudes, or have darker skin are at meaningful risk of deficiency. The problem is not rare or niche; it is the default for a large share of the modern population regardless of diet.
03Vitamin D and skin: what the research shows
Skin is one of the most VDR-dense tissues in the body. Keratinocytes (the primary cells of the outer skin layer) both synthesize and respond to vitamin D, giving it a direct role in epidermal health that goes beyond systemic hormone signaling.
Acne and inflammation
The association between vitamin D deficiency and acne is one of the better-documented links in dermatology nutrition research. A 2021 systematic review and meta-analysis found that acne patients had serum 25(OH)D levels averaging 7.66 ng/mL lower than healthy controls, with deficiency present in 48.8% of acne patients versus 22.5% of controls.5 A subsequent systematic review of 10 studies confirmed that 8 of 10 found lower vitamin D levels as acne severity increased.6
The mechanism appears to involve cathelicidin, an antimicrobial peptide. A 2012 in vitro study demonstrated that vitamin D treatment in cultured sebocytes increased expression of hCAP-18 (the cathelicidin precursor to LL-37) in a VDR-dependent manner.10 Cathelicidin is directly active against Cutibacterium acnes, the bacterium implicated in inflammatory acne lesions. In intervention terms: a 2016 RCT of 39 vitamin D-deficient acne patients found that oral supplementation at 1,000 IU/day for two months improved inflammatory lesion counts.7 A separate RCT using active vitamin D (alfacalcidol) found significantly decreased IL-6 and TNF-alpha markers in the treatment group.8
The important qualifier: the intervention benefit appears concentrated in people who are actually deficient. Supplementing vitamin D for acne without a confirmed low level has weaker support in the literature.
Photoaging and UV protection
Active vitamin D (calcitriol) reduces UV-induced DNA damage, enhances cellular repair mechanisms, decreases reactive oxygen species, and increases p53 expression, all documented in a 2020 review in Advances in Experimental Medicine and Biology.20 A 2025 review specifically on vitamin D and skin aging confirmed that adequate vitamin D levels are associated with lower prevalence of age-related skin conditions and supports protection against both chronological and photo-aging.19
This creates an interesting practical tension: the same UVB exposure that causes photoaging also drives vitamin D synthesis. The answer is not to skip SPF; it is to ensure you are not relying on unprotected sun exposure as your only vitamin D source. Most people who live in sun-exposed climates with a sensible supplement stack can maintain adequate vitamin D while still wearing broad-spectrum SPF daily.
Vitamin D supports skin barrier function, antimicrobial defense, and UV-damage repair. Its link to reduced inflammatory acne is one of the stronger associations in dermatology nutrition research, and the RCT data supports supplementation specifically in deficient individuals. Wear SPF; supplement if needed.
04Vitamin D and hair loss: association is strong, causation is still being built
The VDR is expressed in hair follicle keratinocytes, and its role in the hair cycle is distinct from vitamin D's other functions. A landmark review in Archives of Biochemistry and Biophysics showed that VDR loss impairs stem cell self-renewal in the follicle bulge region, preventing the follicle from re-entering the growth phase after shedding.18 Crucially, this effect is ligand-independent: it requires the VDR protein itself, not necessarily high vitamin D levels, which is why the vitamin D and hair relationship is more mechanistically complex than simply "take more D, grow more hair."
That said, the epidemiological associations across hair-loss types are striking. A 2024 meta-analysis of 81 studies covering 15,339 alopecia patients found deficiency rates of roughly 54% in telogen effluvium, 52% in alopecia areata, 50% in female-pattern hair loss, and 47% in androgenetic alopecia, all significantly higher than in healthy controls.11 A separate 2024 meta-analysis of 23 studies found the odds ratio for vitamin D deficiency in non-scarring alopecia was 3.11.12
Telogen effluvium (diffuse shedding)
This is the area with the most direct RCT data. A 2021 clinical trial in 40 patients with telogen effluvium found that fortnightly oral vitamin D3 bolus doses over three months led to hair growth improvement in 82.5% of patients (p<0.001).17 A 2024 observational study found mean 25(OH)D in TE patients was 13.31 ng/mL versus 33.61 ng/mL in healthy controls. After three months of 5,000 IU/day, vitamin D levels rose to 38.4 ng/mL with corresponding clinical improvement in hair density by dermoscopy.16 Both studies enrolled people who were deficient at baseline.
Alopecia areata and androgenetic alopecia
The 2024 Frontiers in Nutrition meta-analysis confirmed statistical significance for lower vitamin D in alopecia areata and female-pattern hair loss versus controls (OR 2.84 and 5.24 respectively).11 For androgenetic alopecia, a Chinese case-control study of 3,947 participants found significantly lower 25(OH)D in both male and female pattern hair loss groups versus healthy controls (P=0.0005).15
The honest read: associations are consistent and odds ratios are meaningful. Direct RCT evidence that supplementing vitamin D reverses hair loss in people who are already vitamin D-sufficient is limited. Correcting a documented deficiency is a clinically reasonable step. Supplementing for hair regrowth without a confirmed deficiency has thinner backing. If you are interested in the broader supplementation picture for hair and skin, our supplement stacking guide covers how these pieces fit together.
Low vitamin D is consistently associated with higher rates of multiple hair-loss types. The VDR's role in follicle cycling explains the mechanism. RCT evidence for supplementation benefit is strongest in people with confirmed deficiency, particularly in telogen effluvium. Test before supplementing.
05Vitamin D and mood: a real signal, not a miracle
VDRs are expressed in brain regions including the hippocampus, prefrontal cortex, and hypothalamus, all involved in mood regulation. Vitamin D modulates serotonin synthesis, regulates dopamine, and suppresses neuroinflammatory pathways, providing a biologically plausible basis for mood effects.
The clinical evidence is genuine, though effect sizes are modest. A 2023 systematic review and meta-analysis of 41 RCTs covering 53,235 participants found that vitamin D supplementation at 2,000 IU or above reduced depressive symptoms with a small-to-moderate effect size (standardized mean difference approximately -0.3), with stronger effects in people already experiencing depression rather than in prevention settings.28 No meaningful effect on anxiety symptoms was found in either that analysis or a 2024 dose-response meta-analysis of 31 RCTs (24,189 participants).29 The 2024 analysis found a dose-response relationship for depression: each additional 1,000 IU/day slightly reduced depressive symptoms, with the strongest dose-response at higher doses.
The pattern mirrors the skin and hair findings: the mood benefit is most reliable when correcting a deficiency, not supplementing beyond sufficiency. People curious about a more integrated approach to mood-relevant supplements can explore our omega-3 benefits explainer, where the evidence profile for mood is complementary and similarly deficiency-driven.
Vitamin D supplementation shows a small-to-moderate effect on depressive symptoms in clinical trials, with effects strongest in people experiencing depression. No meaningful anxiety benefit was found. It is a real signal, not a transformative mood drug, and works best when correcting a documented deficiency.
06Sun exposure, food, and why diet alone usually is not enough
There are three ways to get vitamin D: sunlight, food, and supplements. In practice, for most people in modern life, the first two are insufficient on their own.
Sunlight
Midday UVB exposure on unprotected skin is the most efficient synthesis route. Roughly 10 to 30 minutes of direct sun on the face, arms, and legs at solar noon on a clear summer day may produce 1,000 to 10,000 IU depending on latitude, season, skin tone, and body surface area. The problem: this window is very narrow, varies enormously by geography and season, is near-zero through winter at latitudes above 37 degrees North, and requires unprotected skin that most dermatologists appropriately advise covering for photoaging and skin cancer risk.
A common concern is whether sunscreen blocks synthesis. A large body of evidence suggests the real-world impact is smaller than lab studies imply. A 2019 expert panel review in the British Journal of Dermatology concluded that sunscreens preventing erythema are unlikely to meaningfully compromise vitamin D status in healthy populations.25 A 2025 meta-analysis of 22 studies found sunscreen was associated with only a 2 ng/mL reduction on average, a clinically small difference.26 People apply less sunscreen than lab conditions assume, and any sun on uncovered areas still contributes.
Food
Dietary sources include fatty fish (salmon, sardines, mackerel), egg yolks, beef liver, and fortified products (dairy, plant milks, cereals). The amounts are modest: a 100g serving of wild salmon provides roughly 400 to 600 IU. Hitting even 2,000 IU daily from food alone would require unusually high fish intake. Vitamin D is one of the few nutrients where food is generally not a practical primary source for adequacy.
Supplements
For most people who are deficient, supplements are the most reliable route to correcting levels. The question of dose, form, and cofactors is covered in the next two sections. If you take a wellness supplement stack, checking whether your existing products cover vitamin D at a meaningful dose is a smart first step before adding a standalone product.
07Forms and dosing: what the evidence actually supports
Not all vitamin D supplements are created equal. The two main supplemental forms differ in how effectively they raise serum levels, and standard dose ranges cover a wider window than most labels suggest.
| Form | Common name | Source | Efficacy vs D2 | Typical dose range | Best suited for |
|---|---|---|---|---|---|
| Cholecalciferol | Vitamin D3 | Lanolin (sheep's wool) or lichen (vegan) | Preferred form. Raises 25(OH)D ~15.7 nmol/L more than D2 on average23 | 1,000 to 4,000 IU/day; 2,000 IU covers 99% of adults above 50 nmol/L24 | Most people; closest to skin-synthesized form |
| Ergocalciferol | Vitamin D2 | UV-treated yeast or fungi | Less potent; shorter half-life in the body; still effective for correction | 1,000 to 4,000 IU/day; higher dose may be needed for equivalent effect | Vegan preference where D3 lichen source is unavailable or cost-prohibitive |
| Calcitriol | Active vitamin D (1,25-dihydroxyvitamin D) | Prescription pharmaceutical | Bypasses liver and kidney conversion; potent and narrow therapeutic window | Prescription only; not for general supplementation | Clinical use for kidney disease, hypoparathyroidism, specific dermatology applications |
| Calcifediol | 25-hydroxyvitamin D (semi-activated) | Pharmaceutical | Bypasses liver hydroxylation; raises 25(OH)D faster; used in malabsorption conditions | Prescription or OTC in select markets; not standard first-line choice | Fat malabsorption, liver conditions, rapid correction protocols under guidance |
A practical note on safety: toxicity from vitamin D is rare and primarily caused by sustained excessive supplementation, not from sun exposure (which self-limits via photodegradation). Most documented toxicity cases involved doses above 50,000 IU/day sustained over months, often from manufacturing errors or aggressive self-prescription. The IOM tolerable upper limit is 4,000 IU/day; individual variability means some people are more sensitive. Calcium co-supplementation at high vitamin D doses increases hypercalcemia risk.31
08Cofactors: why magnesium and K2 matter for vitamin D
Vitamin D does not work in isolation. Two cofactors are frequently discussed in the research literature, and both are worth understanding before deciding on a supplementation approach.
Magnesium
Magnesium is a required cofactor for the enzymes that convert vitamin D in both the liver (25-hydroxylation via CYP2R1) and the kidneys (1-alpha-hydroxylation via CYP27B1). Without adequate magnesium, these conversion steps are impaired, meaning you can supplement vitamin D and still fail to activate it properly.32 A 2018 RCT (n=180) found that magnesium supplementation significantly increased serum 25(OH)D when baseline levels were near 30 ng/mL, and that this bidirectional effect reflects magnesium's role in both synthesis and catabolism of vitamin D metabolites.33 Analysis of NHANES data further showed that the protective cardiovascular association of higher vitamin D levels was most pronounced in people with above-median magnesium intake.34
The practical implication: if you are supplementing vitamin D and not seeing expected improvements in serum levels, suboptimal magnesium status is a plausible reason to investigate. Many people are marginally deficient in magnesium given that it is depleted by processed food diets and intensive exercise. Checking our supplement stacking guide covers how to layer these efficiently.
Vitamin K2
The rationale for K2 alongside vitamin D involves calcium routing: vitamin D increases calcium absorption, and K2 (specifically MK-7) activates matrix Gla protein (MGP) and osteocalcin, which direct calcium into bone rather than soft tissue. The concern is that supplementing vitamin D without K2 might increase calcium in arterial walls. A 2022 multicenter double-blind RCT (n=365, 24 months) testing MK-7 plus vitamin D versus placebo found significant biochemical effects but no significant difference in aortic valve calcification progression, the primary clinical endpoint.35 The K2 story is biologically plausible and the biochemical data is interesting; clinical outcome data at supplementation doses is still limited. Many practitioners include MK-7 as a conservative co-supplement alongside higher vitamin D doses.
09Why testing before supplementing actually matters
Vitamin D is fat-soluble, which means unlike water-soluble vitamins it accumulates. Most people supplementing standard doses (1,000 to 2,000 IU) will not approach toxicity thresholds, but the appropriate dose depends directly on your starting level, a number you cannot guess accurately.
A person with 25(OH)D of 10 ng/mL needs a very different protocol from someone at 28 ng/mL who just needs a small nudge. Some people with chronically low levels despite supplementation turn out to have low magnesium; others have gut absorption issues. Testing resolves the guesswork and makes supplementation decisions actually data-driven rather than speculative.
The 25-hydroxyvitamin D test (also called vitamin D 25-OH or 25(OH)D) is the standard test. It is widely available through primary care and many direct-to-consumer lab services. The general interpretation framework: below 20 ng/mL is deficient and warrants correction; 20 to 29 ng/mL is insufficient and warrants supplementation; 30 ng/mL and above is adequate for most; 40 to 60 ng/mL is the range many functional medicine practitioners target; above 100 ng/mL starts raising toxicity concerns at sustained levels. For a broader look at how vitamin D fits into a performance and appearance-focused supplementation approach, see the looksmaxxing supplements overview.
Get tested before choosing a dose. A 25(OH)D blood test is inexpensive and widely available. It tells you whether you are deficient, insufficient, or already adequate, which determines whether supplementing will actually change anything for your skin, hair, or mood.
10Frequently asked questions
Vitamin D supports calcium absorption and bone density, immune regulation, and mood. Research also links adequate levels to healthier skin barrier function, lower rates of inflammatory acne lesions in deficient individuals, and better outcomes in several types of hair loss including telogen effluvium and alopecia areata. Most functional benefits require actually correcting a deficiency first. People with already-adequate levels see smaller gains from supplementing further.
Most labs flag deficiency below 20 ng/mL (50 nmol/L). Insufficiency is 20 to 29 ng/mL. Adequacy for most health outcomes starts around 30 ng/mL (75 nmol/L), with some research suggesting optimal ranges for specific endpoints sit closer to 40 to 50 ng/mL.22 The only reliable way to know your status is a 25-hydroxyvitamin D blood test.
The association between low vitamin D and hair loss is well-documented across multiple types. A 2024 meta-analysis of 81 studies found deficiency in roughly 50% of alopecia areata patients, with odds ratios of 2.84 to 5.24 across non-scarring types versus healthy controls.11 Correcting a documented deficiency is a reasonable first step, supported by RCT evidence in telogen effluvium patients. Supplementing beyond sufficiency as a hair-growth strategy has weaker evidence.
Vitamin D supports skin barrier function, immune defense via cathelicidin, and anti-inflammatory signaling. Deficiency was found in roughly 49% of acne patients versus 22% of healthy controls, and RCTs show supplementation improves inflammatory lesions in deficient individuals.5 It also supports DNA repair after UV exposure and may slow aspects of photoaging.19 Topical calcitriol is a separate prescription treatment used in clinical dermatology; it is not the same as oral vitamin D supplementation.
In theory yes, but real-world evidence is more reassuring. A British Journal of Dermatology systematic review and an international expert panel both concluded that daily sunscreen use in realistic conditions does not meaningfully reduce serum 25(OH)D levels.25 A 2025 meta-analysis found sunscreen was associated with only a 2 ng/mL reduction on average.26 Wear your SPF; supplement if needed.
Vitamin D3 (cholecalciferol) is more effective than D2 (ergocalciferol) at raising serum 25(OH)D. A meta-analysis of 24 controlled trials found D3 raised vitamin D levels 15.69 nmol/L more than D2 on average.23 D3 from lichen is the vegan-suitable option. Most mainstream supplements use D3 from lanolin (sheep's wool).
1,000 to 2,000 IU of vitamin D3 daily covers most adults with mild-to-moderate deficiency safely. A 2024 review found 2,000 IU raised 25(OH)D above 50 nmol/L in over 99% of adults.24 Higher doses (3,200 to 4,000 IU) carry a small elevated risk of hypercalcemia per a 2023 meta-analysis.30 The right dose for any individual depends on baseline blood levels, which is exactly why testing first makes more sense than guessing.
The evidence is real but modest. A 2023 meta-analysis of 41 RCTs (53,235 participants) found vitamin D supplementation at 2,000 IU or above reduced depressive symptoms with a small-to-moderate effect size (SMD around -0.3), with effects consistently stronger in people already experiencing depression.28 A 2024 dose-response meta-analysis found each additional 1,000 IU/day slightly reduced depressive symptoms, with no meaningful effect on anxiety in either analysis.29
Common signs that may accompany low vitamin D include persistent fatigue, low mood, muscle weakness, bone achiness, and more frequent illness. Hair shedding and slow skin recovery can also be associated with deficiency. These symptoms overlap with many other conditions, so they are not diagnostic on their own. The only reliable way to confirm a deficiency is a 25-hydroxyvitamin D blood test. See a healthcare professional if you have concerns.
Vitamin D supports five core functions in the body: (1) calcium and phosphorus absorption to maintain bone density, (2) immune system regulation including antimicrobial defense via cathelicidin, (3) muscle function and neuromuscular coordination, (4) mood and nervous system signaling linked to serotonin pathways, and (5) skin barrier integrity and cellular repair after UV exposure. Most of these functions depend on maintaining adequate blood levels, not just taking a supplement.
// Sources and references
- Sowah D, et al. "Vitamin D levels and deficiency with different occupations: a systematic review." BMC Public Health. 2017;17:519. PubMed 28637448
- Elsherbiny NM, et al. "High Incidence of Vitamin D Deficiency (VDD) Among Indoor Workers." Ecol Food Nutr. 2024. PubMed 38282295
- Palacios C, Gonzalez L. "The prevalence of vitamin D deficiency among dark-skinned populations: a meta-analysis." Nutrition. 2016;32(3):430-436. PubMed 26643747
- Bouillon R, et al. "Does high prevalence of vitamin D deficiency in African Americans contribute to health disparities?" Nutrients. 2021;13(2):499. PubMed 33546262
- Lim SK, et al. "Vitamin D status and efficacy of vitamin D supplementation in acne patients: a systematic review and meta-analysis." J Cosmet Dermatol. 2021;20(5):1390-1398. PubMed 33690970
- Bagatin E, et al. "Correlation between serum 25-hydroxy vitamin D levels and the severity of acne vulgaris: a systematic review." Indian J Dermatol. 2022;67(2):223. PubMed 35656233
- Lim SK, et al. "Comparison of vitamin D levels in patients with and without acne: a case-control study combined with a randomized controlled trial." PLoS One. 2016;11(8):e0161162. PubMed 27560161
- Abdelaziz Ahmed M. "The impact of active vitamin D administration on the clinical outcomes of acne vulgaris." J Dermatolog Treat. 2021;32(2):207-212. PubMed 31868550
- Adalsteinsson JA, et al. "Vitamin D levels in patients with and without acne and its relation to acne severity: a case-control study." Clin Cosmet Investig Dermatol. 2020;13:789-795. PubMed 33116739
- Lee WJ, et al. "Vitamin D increases expression of cathelicidin in cultured sebocytes." Arch Dermatol Res. 2012;304(4):307-312. PubMed 22695798
- Wang J, et al. "Vitamin D deficiency in non-scarring and scarring alopecias: a systematic review and meta-analysis." Front Nutr. 2024;11:1479337. PMC 11479915
- Famenini S, et al. "Serum 25 hydroxyvitamin D in non-scarring alopecia: a systematic review and meta-analysis." J Cosmet Dermatol. 2024;23(1):15-22. PubMed 38010941
- Mysore V, et al. "Prevalence of low serum vitamin D levels in patients presenting with androgenetic alopecia: a review." Cureus. 2021;13(12):e20431. PubMed 35047268
- Cheung EJ, et al. "Study of serum vitamin D levels in men with premature androgenetic alopecia." Int J Dermatol. 2020;59(9):1113-1118. PubMed 32516435
- Zhao J, et al. "Serum 25 hydroxyvitamin D levels in alopecia areata, female pattern hair loss, and male androgenetic alopecia in a Chinese population." J Cosmet Dermatol. 2020;19(12):3280-3285. PubMed 32275116
- Erpolat S, et al. "Oral vitamin D treatment in patients with telogen effluvium: clinical and dermoscopic evaluation." Int J Trichology. 2024;16(1):8-14. PMC 11335050
- Dobrescu A, et al. "Efficacy of oral vitamin D3 therapy in patients suffering from diffuse hair loss (telogen effluvium)." J Nutr Sci Vitaminol. 2021;67(1):68-72. PubMed 33642467
- Bikle DD, et al. "The hair cycle and vitamin D receptor." Arch Biochem Biophys. 2012;523(1):19-28. PubMed 22008469
- Ratz-Lyko A, Arct J. "Impact of vitamin D on skin aging and age-related dermatological conditions." Front Biosci (Landmark Ed). 2025;30(2). PubMed 39862075
- Reichrath J, et al. "Protection from ultraviolet damage and photocarcinogenesis by vitamin D compounds." Adv Exp Med Biol. 2020;1268:227-260. PubMed 32918222
- Holick MF. "Vitamin D deficiency." N Engl J Med. 2007;357(3):266-281. PubMed 17634462
- Grant WB, et al. "A narrative review of the evidence for variations in serum 25-hydroxyvitamin D concentration thresholds for optimal health." Nutrients. 2022;14(3):639. PubMed 35276999
- Tripkovic L, et al. "Relative efficacy of vitamin D2 and vitamin D3 in improving vitamin D status: systematic review and meta-analysis." Nutrients. 2021;13(10):3328. PubMed 34684328
- Cashman KD. "Vitamin D supplementation: a review of the evidence arguing for a daily dose of 2000 IU for adults in the general population." Nutrients. 2024;16(3):391. PMC 10857599
- Passeron T, et al. "Sunscreen photoprotection and vitamin D status." Br J Dermatol. 2019;181(5):916-931. PubMed 31069788
- de Gruijl FR, et al. "Sunscreen and 25-hydroxyvitamin D levels: friends or foes? A systematic review and meta-analysis." Endocr Pract. 2025. PubMed 40246233
- Neale RE, et al. "The effect of sunscreen on vitamin D: a review." Br J Dermatol. 2019;181(5):907-915. PubMed 30945275
- Shaffer JA, et al. "The effect of vitamin D supplementation on depressive symptoms in adults: a systematic review and meta-analysis of randomized controlled trials." Crit Rev Food Sci Nutr. 2023;63(20):4511-4525. PubMed 35816192
- Kaviani M, et al. "The effect of vitamin D supplementation on depression: a systematic review and dose-response meta-analysis of randomized controlled trials." Psychol Med. 2024. PubMed 39552387
- Malihi Z, et al. "Long-term supplementation with 3200 to 4000 IU of vitamin D daily and adverse events: a systematic review and meta-analysis of randomized controlled trials." Eur J Nutr. 2023;62(4):1833-1844. PubMed 36853379
- Marcinowska-Suchowierska E, et al. "Vitamin D toxicity." StatPearls. 2024. NBK557876
- Uwitonze AM, Razzaque MS. "Role of magnesium in vitamin D activation and function." J Am Osteopath Assoc. 2018;118(3):181-189. PubMed 29480918
- Deng X, et al. "Magnesium status and supplementation influence vitamin D status and metabolism: results from a randomized trial." Am J Clin Nutr. 2018;108(6):1249-1258. PubMed 30541089
- Rosanoff A, Dai Q, Shapses SA. "Magnesium deficit: overlooked cause of low vitamin D status?" BMC Med. 2013;11:229. PubMed 24228832
- Veulemans V, et al. "Vitamin K2 and D in patients with aortic valve calcification: a randomized double-blinded clinical trial." Circulation. 2022;145(22):1619-1629. PubMed 35465686